Compliance

Compliance

FDA Advisory Committee Recommends Six of Seven Peptides for the 503A Compounding List: What It Means for Your Business

Frier Levitt attorneys break down the July 2026 PCAC votes on BPC-157, KPV, TB-500, MOTS-c, DSIP, Epitalon, and Semax, and what compounders,…

Sep 10, 2026 / 15 min read

Compliance

Pharmacy Audit Readiness: Documentation Habits That Reduce Operational Risk

A practical pharmacy audit-readiness framework: record maps, controlled responses, documentation habits, production logs, and internal review.

Sep 10, 2026 / 10 min read

Compliance

Controlled-Substance Red Flags: What a Community Pharmacy Policy Should Cover

A respectful, practical controlled-substance policy framework for pharmacy teams: escalation, documentation, patient communication, and role boundaries.

Jul 30, 2026 / 10 min read

Compliance

DSCSA 2026 for Dispensers: Receiving, Verification, and Exception Handling

A practical DSCSA 2026 workflow for dispensers: receiving controls, small-dispenser exemption scope, exception handling, and escalation.

Jul 28, 2026 / 11 min read

Clinical

Navigating Clinical Research Manufacturing: A Guide for Compounding Pharmacies Entering Phase 1 Clinical Trials

A practical guide for compounding pharmacies entering Phase 1 clinical trials, with emphasis on cGMP, quality control, documentation, and FDA compliance.

Jul 9, 2026 / 5 min read